Little Cara steers through their first positive PhIII with a ‘breakthrough’ drug and a path to the FDA
Cara Therapeutics $CARA has successfully hit a key milestone in its push to get their lead drug across the finish line at the FDA. The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
